Listed by the USPTO as SWANSON, LEAH JENNINGS
Tech Center 3700 • Art Units: 3763 3783
This examiner grants 66% of resolved cases
SWANSON, LEAH JENNINGS works in Tech Center 3700 and art unit 3763. The profile contains 439 resolved cases, a 65.6% allowance rate, and a 38.4% interview lift. The median time to allowance is 1228 days. The interview figure is a significant part of this profile, indicating that interview-focused prosecution may deserve deliberate attention when developing an application strategy.
The leading companies are Insulet Corporation, Cardinal Health Inc., and Becton, Dickinson and Company. The listed firms are Knobbe, Martens, Olson & Bear, LLP, Goodwin Procter LLP, and Kirton McConkie. Practitioners can use this combination of company and firm activity to assess whether the examiner’s recorded docket aligns with a client’s subject matter and counsel resources.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17888048 | CATHETER ASSEMBLY | Final Rejection | TERUMO KABUSHIKI KAISHA |
| 18912132 | FILTER FOR IV SET | Non-Final OA | CareFusion 303, Inc. |
| 18514022 | FLUID LINE OCCLUSION DETECTION SYSTEM AND METHODS | Final Rejection | CareFusion 303, Inc. |
| 17361762 | CLOSED LOOP CONTROL SYSTEM WITH SAFETY PARAMETERS AND METHODS | Final Rejection | Abbott Diabetes Care Inc. |
| 18571423 | ADVANCED EAR ACCESS | Non-Final OA | COCHLEAR LIMITED |
| 17208994 | CATHETER ADAPTER PUSH TAB AND RELATED DEVICES, SYSTEMS, AND METHODS | Non-Final OA | Becton, Dickinson and Company |
| 16889398 | CATHETER ASSEMBLY FLUSHING DEVICE AND RELATED METHODS | Non-Final OA | Becton, Dickinson and Company |
| 18386647 | PROGRAMMATIC MEDICAMENT TITRATION WITH A MEDICAMENT DELIVERY DEVICE | Final Rejection | INSULET CORPORATION |
| 16995527 | RATCHET DRIVE FOR ON BODY DELIVERY SYSTEM | Final Rejection | Insulet Corporation |
| 16859544 | FILLING ASSIST MECHANISMS AND KEYED INTERFACES FOR DRUG DELIVERY DEVICES | Final Rejection | INSULET CORPORATION |
| 18251522 | DEVICE ASSEMBLY FOR NEEDLELESS SYRINGE | Final Rejection | DAICEL CORPORATION |
| 18268400 | FLUID DELIVERY SYSTEM AND RELATED METHODS OF USE | Final Rejection | The Penn State Research Foundation |
| 18292133 | SPARK GENERATOR FOR GENERATING PRESSURE, FORMULA INJECTOR COMPRISING SPARK GENERATOR, METHOD FOR GENERATING PRESSURE BY SPARK, AND METHOD FOR INJECTING FORMULA | Non-Final OA | L'Oreal |
| 18199599 | RESORBABLE, DRUG-ELUTING SUBMUCOSAL TURBINATE IMPLANT DEVICE AND METHOD | Final Rejection | Medtronic Xomed, Inc. |
| 17509196 | Microneedle Systems and Apparatus | Final Rejection | DEKA Products Limited Partnership |
| 18597028 | Integrating Electronics into the Stopper of a Cartridge | Final Rejection | Sanofi |
| 18145564 | Auto-Injector | Final Rejection | Sanofi-Aventis Deutschland GMBH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy65.6% of resolved applications examined by Leah Jennings Swanson were allowed (439 resolved cases), compared with 60.3% across Art Unit 3763 over the last five years.
This examiner's interview lift is +38.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Leah Jennings Swanson took 1,228 days on average from filing to allowance.
Leah Jennings Swanson examines applications in Art Unit 3763 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
